Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

Ionizable lipid nanoparticles (LNPs) have gained attention as mRNA delivery platforms for vaccination against COVID-19 and for protein replacement therapies. LNPs enhance mRNA stability, circulation time, cellular uptake, and preferential delivery to specific tissues compared to mRNA with no carrier...

Full description

Bibliographic Details
Main Authors: Rachel E. Young, Katherine M. Nelson, Samuel I. Hofbauer, Tara Vijayakumar, Mohamad-Gabriel Alameh, Drew Weissman, Charalampos Papachristou, Jason P. Gleghorn, Rachel S. Riley
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-04-01
Series:Bioactive Materials
Subjects:
Lipid nanoparticles (LNPs)
Drug delivery
Nucleic acids
Placental growth factor (PlGF)
Placenta
Pregnancy
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X23003638

Internet

http://www.sciencedirect.com/science/article/pii/S2452199X23003638

Similar Items